Evidence map›Paper›PMID 30062635›Full record

ArticleCEN case reports2019

A case of IgG4-related kidney disease with predominantly unilateral renal atrophy.

Akari Takeji, Kazunori Yamada, Dai Inoue, Ichiro Mizushima, Satoshi Hara, Kiyoaki Ito, Hiroshi Fujii, Kenichi Nakajima, Kazuaki Mizutomi, Masakazu Yamagishi and 1 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in CEN case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Akari TakejiDivision of Rheumatology, Kanazawa University Hospital, Kanazawa University Graduate School of Medicine, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-8640, Japan.
Kazunori YamadaDivision of Rheumatology, Kanazawa University Hospital, Kanazawa University Graduate School of Medicine, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-8640, Japan.
Dai InoueDepartment of Radiology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan.
Ichiro MizushimaDivision of Rheumatology, Kanazawa University Hospital, Kanazawa University Graduate School of Medicine, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-8640, Japan.
Satoshi HaraDivision of Rheumatology, Kanazawa University Hospital, Kanazawa University Graduate School of Medicine, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-8640, Japan.
Kiyoaki ItoDivision of Rheumatology, Kanazawa University Hospital, Kanazawa University Graduate School of Medicine, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-8640, Japan.
Hiroshi FujiiDivision of Rheumatology, Kanazawa University Hospital, Kanazawa University Graduate School of Medicine, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-8640, Japan.
Kenichi NakajimaDepartment of Nuclear Medicine, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
Kazuaki MizutomiInternal Medicine, Kaga Medical Center, Kaga, Ishikawa, Japan.
Masakazu YamagishiDivision of Cardiology, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan.
Mitsuhiro KawanoDivision of Rheumatology, Kanazawa University Hospital, Kanazawa University Graduate School of Medicine, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-8640, Japan. sk33166@gmail.com.
Kanazawa University Hospital · JPKanazawa University · JPShiga Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 73-year-old Japanese woman was diagnosed with type 1 autoimmune pancreatitis (AIP) without kidney lesions. She was treated with prednisolone (PSL) 30 mg/day, and her AIP symptoms promptly improved, after which the PSL dose was gradually tapered to 5 mg/day. Her renal function had remained normal (serum creatinine 0.7 mg/dL) until 1 year before the current admission without any imaging abnormalities in the kidney. However, during this past year her renal function gradually declined (serum creatinine 1.1 mg/dL). Follow-up computed tomography incidentally revealed unilateral renal atrophy, which rapidly progressed during the subsequent 10-month period without left kidney atrophy. A diagnosis of IgG4-RKD probably due to TIN was made, and we increased the dose of prednisolone to 30 mg/day. 1 month after administration, multiple low-density lesions on both kidneys were improved slightly but almost all lesions persisted as atrophic scars. Our case suggested that unilateral renal atrophy can develop in patients with IgG4-related tubulointerstitial nephritis without hydronephrosis caused by retroperitoneal fibrosis, and that monitoring the serum creatinine levels is not always sufficient, thereby highlighting the importance of regular imaging monitoring to detect newly developing kidney lesions.

Indexed as

Acute DiseaseAgedAtrophyAutoimmune DiseasesFemaleGlucocorticoidsHumansImmunoglobulin GImmunoglobulin G4-Related DiseaseKidneyNephritis, InterstitialPancreatitisTomography, X-Ray ComputedGlucocorticoidsImmunoglobulin GIgG4-related diseaseIgG4-related kidney diseaseTubulointerstitial nephritisUnilateral renal atrophy

Identifiers

PMID30062635
PMCPMC6361077
OpenAlexW2887068908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.